MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Drooling in Parkinson’s Disease: A [123I]FP-CIT SPECT study

    V. Suarez Contreras, Y. Tayyabah, S. Caminiti, M. Politis (London, United Kingdom)

    Objective: Evaluate the association between drooling and striatal dopamine terminals. Test the assumption that drooling correlates with disease progression in de novo Parkinson’s disease (PD)…
  • 2019 International Congress

    Association between quality of life and physical functions in patients with idiopathic Parkinson’s disease

    BO. Ugut, T. Kahraman, AC. Kalkan, B. Donmez Colakoglu, A. Genc (Izmir, Turkey)

    Objective: The aim was to investigate the association between health-related quality of life and physical functions in the patients with idiopathic Parkinson's disease (PD). Background:…
  • 2019 International Congress

    131-MIBG is less promising in differentiating Parkinson’s disease from other parkinsonism for early onset patients

    D. Xu, WJ. Zhu, H. Wang, L. Huo (Beijing, China)

    Objective: To investigate the diagnostic value of 131I-MIBG cardiac scintigraphy in differentiating PD from other parkinsonism for distinct age of onset. Background: MIBG cardiac sympathetic imaging has…
  • 2019 International Congress

    Levodopa Induced dyskinesia in patients with Parkinson’s disease and polymorphisms gene DRD3 dopamine receptor

    I. Zhukova, N. Zhukova, E. Kolupaeva, S. Ivanova, M. Nikitina, O. Izhboldina, I. Mironova (Tomsk, Russian Federation)

    Objective: The aim of this study was to investigate the association between two DRD3 gene single-nucleotide polymorphisms (SNPs) and the development of LID in patients…
  • 2019 International Congress

    Neuroprotective actions of red propolis extract and formononetin in a rat model of Parkinson’s disease

    M. Gomes, S. Barroso, J. de Oliveira, D. Marques, A. Santos, J. Cardoso (Aracaju, Brazil)

    Objective: To evaluate the effects of the hydroalcoholic extract of red propolis (HERP) and one of its major compounds, formononetin (FN), against the motor symptoms…
  • 2019 International Congress

    Oscillaotory activity in the globus pallidus internus in patients with Parkinson’s disease

    P. Zhuang, M. Hallett, D. Meng, Y. Zhang, J. Li, J. Li (Beijing, China)

    Objective: To quantify the characteristics of oscillatory neurons in the GPi in patients with PD. Background: Abnormal oscillatory activity has been predicted to play a…
  • 2019 International Congress

    Mindfulness Training to Reduce Anxiety in Parkinson’s Disease: A Cautionary Tale about Wearable Technology

    D. Mohanty, A. Lingaiah, J. Doak, A. Jacob, R. Castellanos, V. Holiday, A. Espay, K. Lafaver (Louisville, KY, USA)

    Objective: This study aimed to determine the feasibility of using a non-pharmacologic intervention (mindfulness training; MT) administered with a wearable tracker to alleviate anxiety through…
  • 2019 International Congress

    Motor and non-motor symptoms related to sleep disturbances in Parkinson’s disease

    D. van Wamelen, V. Leta, A. Podlewska, Y. Wan, A. Sauerbier, A. Rizos, P. Martinez-Martin, K. Chaudhuri (Madrid, Spain)

    Objective: To assess which (non-)motor symptoms are associated with the longitudinal development of sleep disturbances, one of the major non-motor symptoms (NMS) in Parkinson’s disease…
  • 2019 International Congress

    Body Representation Impairments in Parkinson’s disease: A Preliminary Report

    J. Cardona, C. Martinez, W. Correa, J. Grisales, C. Trujillo, F. Marmolejo-Ramos (Santiago de Cali, Colombia)

    Objective: The current study investigates semantic processing (SP) and body representation (BR) in early Parkinson’s disease patients (ePDp) compared with neurologically healthy participants. Background: Although…
  • 2019 International Congress

    Plasma Soluble ST2 (sST2) levels are Higher in Neurodegeneration and Associate with PD Cognition

    ASL. Ng, YJ. Tan, ACW. Yong, BYX. Wong, ZH. Lu, SYE. Ng, SKS. Ting, S. Hameed, L. Zeng, N. Kandiah, WL. Au, LCS. Tan (Singapore, Singapore)

    Objective: As plasma IL-33 levels are too low to accurately quantify, we measured plasma sST2 as a surrogate marker for IL-33 in samples from healthy…
  • « Previous Page
  • 1
  • …
  • 178
  • 179
  • 180
  • 181
  • 182
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley